Skip to content

Transorb TSB4030Recalls & reported problems

Sofradim Production · Self-Gripping Resorbable Mesh Monofilament PLLA/TMC Textile and Grips · Class 2 · Implant

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10884521809734), received between Mar 13, 2025 and Jul 2, 2025 — classified as 2 injuries, 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Hematoma1
  • Seroma1
  • Unintended Radiation Exposure1
  • Unspecified Tissue Injury1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 2, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT PRIOR MESH INFECTION UNDERWENT A PANNICULECTOMY PROCEDURE, DURING WHICH THE MESH WAS IMPLANTED. POSTOPERATIVELY, A NON-SYMPTOMATIC SEROMA DEVELOPED, ATTRIBUTED TO THE PANNICULECTOMY, AND REQUIRED SURGICAL TREATMENT. THE SEROMA WAS NOT CONSIDERED RELATED TO THE STUDY MESH OR OUTSIDE STANDARD OF CARE PROCEDURES BY THE INVESTIGATOR. THE PATIENT WAS REPORTED TO BE RECOVERING OR RESOLVING.

    Patient problems: Seroma

    MAUDE report 22382881 ↗
  • MalfunctionMar 27, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT WITH OBESITY, DIABETES MELLITUS, AND HYPERTENSION UNDERWENT LAPAROSCOPIC SURGERY FOR A VENTRAL HERNIA WITH INTRAPERITONEAL MESH PLACEMENT USING THE DEVICE. FOLLOWING THE PROCEDURE, A HEMATOMA DEVELOPED IN THE RETROUMBILICAL SUBCUTANEOUS SOFT TISSUE. AN X-RAY CONDUCTED ON (B)(6) 2025, CONFIRMED THE PRESENCE OF THE HEMATOMA, WHICH WAS DEEMED CLINICALLY SIGNIFICANT.

    Patient problems: Hematoma; Unintended Radiation Exposure

    MAUDE report 21709526 ↗
  • InjuryMar 13, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING AN OPEN VENTRAL HERNIA REPAIR USING AN ABSORBABLE MESH, A POST-OPERATIVE COMPLICATION OCCURRED, LEADING TO THE EXPLANATION OF THE MESH. THE PROCEDURE INVOLVED A TRANSVERSUS ABDOMINIS RELEASE IN THE MIDDLE ABDOMEN. THE PATIENT RETURNED TO THE EMERGENCY ROOM SEVERAL DAYS AFTER THE INITIAL PROCEDURE. THE MESH WAS REMOVED DUE TO THE COMPLICATION.

    Patient problems: Unspecified Tissue Injury

    MAUDE report 21602261 ↗

Other Mesh, surgical, absorbable, abdominal hernia devices

All Mesh, surgical, absorbable, abdominal hernia devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.